Coronary artery diseaseComparison of Short- (One Month) and Long- (Twelve Months) Term Outcomes of Sirolimus- Versus Paclitaxel-Eluting Stents in 293 Consecutive Patients With Diabetes Mellitus (from the RESEARCH and T-SEARCH Registries)
References (10)
- et al.
The unrestricted use of paclitaxel versus sirolimus-eluting stents for coronary artery disease in an unselected population—one year results of the Taxus-Stent Evaluated At Rotterdam Cardiology Hospital (T-SEARCH) Registry
J Am Coll Cardiol
(2005) - et al.
Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromesinsights from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry
J Am Coll Cardiol
(2003) - et al.
Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the “real world”the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry
Circulation
(2004) - et al.
Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions
Circulation
(2003) - et al.
ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelinesA report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty)
J Am Coll Cardiol
(2001)
There are more references available in the full text version of this article.
Cited by (0)
This study was supported by the Erasmus MC, Rotterdam, The Netherlands, and by unrestricted institutional grants from Boston Scientific Corp., Natick, Massachusetts, and Cordis, a Johnson & Johnson Company, Miami Lakes, Florida.
Copyright © 2005 Elsevier Inc. All rights reserved.